Monthly gemcitabine (days 1, 8 and 15) plus cisplatin (days 1-3) in advanced non-small cell lung cancer: A phase II study

Ofer Merimsky*, Nely Wigler, Yoel Greif, Yehuda Schwartz, Noam Asna, Paz Joseph, Avraham Mann, Moshe Inbar

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Monthly gemcitabine (days 1, 8 and 15) plus cisplatin (days 1-3) in advanced non-small cell lung cancer: A phase II study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology